**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 977-96-8 |Quinolinium,1-ethyl-2-(1-ethyl-2(1h)-q| 99 | 213-556-6 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T
Risk Phrases: 23/24/25
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Toxic by inhalation, in contact with skin and if swallowed.Light
sensitive.The toxicological properties of this material have not been
fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological
properties of this substance have not been fully investigated.
Chronic ingestion of iodides during pregnancy has resulted in fetal
death, severe goiter, and cretinoid appearance of the newborn.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated.
Chronic:
Chronic ingestion of iodides during pregnancy has resulted in fetal
death, severe goiter, and cretinoid appearance of the newborn..
Prolonged exposure to iodides may produce iodism in sensitive
individuals. Symptoms could include skin rash, running nose and
headache.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Get medical aid. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation. If breathing has ceased apply artificial respiration
using oxygen and a suitable mechanical device such as a bag and a
mask.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry
chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Avoid ingestion and
inhalation. Store protected from light.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Store
protected from light.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 977-96-8:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystals
Color: dark red
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 273 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: > 273 deg C
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C23H23IN2
Molecular Weight: 454.34
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, light, dust generation, excess heat, strong
oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, irritating and toxic fumes and
gases, carbon dioxide, hydrogen iodide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 977-96-8 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Quinolinium,1-ethyl-2-(1-ethyl-2(1h)-quinolinylidene)methyl, -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 23/24/25 Toxic by inhalation, in contact with skin
and if swallowed.
Safety Phrases:
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 977-96-8: No information available.
Canada
CAS# 977-96-8 is listed on Canada's DSL List.
CAS# 977-96-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 977-96-8 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 6/28/1999 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
N-Propyl Acetate, 99+%
| 109-60-4 |
|
Rhodizonic acid dipotassium salt, 95% (uv-vis)
| 13021-40-4 |
|
delta-Valerolactone, 99%
| 542-28-9 |
|
Octaethylporphine
| 2683-82-1 |
|
(2r,4r)-(-)-pentanediol, 99%
| 42075-32-1 |
|
3'-Chloropropiophenone, 98%
| 34841-35-5 |
|
16-Doxyl-Stearic Acid, Free Radical
| 53034-38-1 |
|
(Trifluoromethoxy)benzene, 99+%
| 456-55-3 |
|
N-Butyramide 99%
| 541-35-5 |
|
O-Acetylmandelic acid chloride, 95%
| 1638-63-7 |
|
2-Ethylhexyl cyanoacetate, 98+%
| 13361-34-7 |
|
Pyruvic aldehyde dimethyl acetal, 98%
| 6342-56-9 |
|
1,1'-Diethyl-2,2'-Cyanine Iodide, 99% (UV-Vis)
| 977-96-8 |
|
Isophthaloyl dichloride, 98%
| 99-63-8 |
|
Dibutyltin diacetate, pract.
| 1067-33-0 |
|
Methyl cinnamate, 98%
| 103-26-4 |
|
L-Cystine Dimethyl Ester Dihydrochloride
| 32854-09-4 |
|
Corn Oil, U.S.P./N.F.
| 8001-30-7 |
|
3-Iodobenzylamine hydrochloride, 97%
| 3718-88-5 |
|
4-Phenoxyphenol, 99%
| 831-82-3 |
|
1,10-Phenanthroline monohydrochloride monohydrate, 97%
| 3829-86-5 |
|
Ethyl 3-N-Ethyl-Aminoacrylate
| 55330-56-8 |
|
Phenetole, 99%
| 103-73-1 |
|
Nickel atomic absorption standard solution, 1 mg/ml Ni in 2% HNO3
| 7440-02-0 |
|
Ethyl Glycolate, 95% (GC)
| 623-50-7 |
|
Magnesium Fluoride, 98+%
| 7783-40-6 |
|
Homovanillic Acid, 98%
| 306-08-1 |
|
(R,R)-(-)-1,2-Dicyclohexyl-1,2-Ethanediol, 99%
| 120850-92-2 |
|
Methyl nicotinate, 99%
| 93-60-7 |
|
D-(+)-Talose, 99%
| 2595-98-4 |
|
1,3-Phenylenediacetic acid, 97%
| 19806-17-8 |
|
Ethyl 4-bromocrotonate, tech., 75%
| 37746-78-4 |
|
(s)-(-)-alpha-(1-Naphtyl)ethylamine, 99+%,
| 10420-89-0 |
|
Homophthalic acid, 99%
| 89-51-0 |
|
p-Xylene-alpha,alpha,alpha,alpha',alpha',alpha'-d6, 99+ atom % D
| 106-42-3 |
|
Coumestrol, 99% (UV-Vis)
| 479-13-0 |
|
2-Amino-5-nitropyridine, 99%
| 4214-76-0 |
|
2-Amino-5-Chlorobenzoxazole, 97%
| 61-80-3 |
|
alpha-Naphtholphthalein, indicator
| 596-01-0 |
|
3-Picoline, 99.5+%
| 108-99-6 |
|
Chromium(vi) oxide pyridine complex
| 20492-50-6 |
|
N-Butylcarbamate, 97%
| 592-35-8 |
|
6-Bromo-7-Nitroquinoxaline, 95%
| 113269-09-3 |
|
n-2-Acetylguanine, 99+%
| 19962-37-9 |
|
1,2:5,6-Di-O-Isopropylidene-Alpha-D-Allofuranose, 98%
| 2595-05-3 |
|
N-Cyanoimido Dimethyl Carbonate, 95% (on Dry Substance)
| 0-00-1 |
|
l-(-)-Glyceraldehyde 90 wt% aqueous solution
| 497-09-6 |
|
5-Aminoisophthalic Acid, 98+%(Titr.; Dry Substance)
| 99-31-0 |
|
Flufenamic Acid, 97%
| 530-78-9 |
|
Lipase AY30, according to amano's specification
| 9001-62-1 |
|
|